Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

North Africa medtech opportunities re-emerging, but risks need to be weighed

This article was originally published in Clinica

Executive Summary

Away from the BRIC markets, but also showing much potential for growth, the countries of North Africa represent a potentially lucrative, often overlooked, opportunity. The “Arab spring” events, which sparked in Tunisia in December 2010 and spread to Egypt, Morocco, Algeria and Libya in 2011, did much to close down local business prospects. But with stability now coming to the markets, global medtech manufacturers are once more eyeing the potential of this import-dominated region.